Learn about key market drivers and leading companies shaping the U.S. hormone refractory prostate cancer landscape, including next-generation therapies and strategic collaborations in CRPC treatment. https://www.openpr.com/news/4318357/united-states-hormone-refractory-prostate-cancer-market